ALCOR — Biocorp Production SA Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall Cap
- €154.39m
- €157.50m
- €11.67m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 113.23 | ||
| PEG Ratio (f) | 1.2 | ||
| EPS Growth (f) | 1,604.4% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 61.5 | ||
| Price to Tang. Book | 62.52 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 12.97 | ||
| EV to EBITDA | 12,678.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.79% | ||
| Return on Equity | -23.33% | ||
| Operating Margin | -7.31% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 3.89 | 8.45 | 8.46 | 10.23 | 11.67 | 17 | 23 | 38.13% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +234.62 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Biocorp Production SA is a France-based company, which is specialised in the development and manufacturing of medical and drug delivery devices.
Directors
- Jacques Gardette CHM
- Eric Dessertenne CEO
- Stephane Chabanais FID
- Alexia Garin OTH
- Thierry Guillemaut OTH
- Arnaud Guillet OTH
- Xavier Julia OTH
- Alain Marcoz OTH
- Jean-Yves Berthon DRC
- Emilie Gardette DRC
- Julien Gardette DRC
- Stephane Legastelois DRC
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2022
- Incorporated
- May 10th, 2004
- Public Since
- July 10th, 2015
- No. of Employees
- 80
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 4,398,587
- Address
- Parc Technologique Lavaur-la-Bechade, ISSOIRE, 63500
- Web
- https://biocorpsys.com/
- Phone
- +33 473557050
- Auditors
- Grant Thornton International
Upcoming Events for ALCOR
Similar to ALCOR
AB Science SA
Euronext - Paris
Advicenne SA
Euronext - Paris
Aelis Farma SA
Euronext - Paris
Boiron SA
Euronext - Paris
DBV Technologies SA
Euronext - Paris
FAQ
What is the Biocorp Production SA share price?
As of Today at 01:04 UTC, shares in Biocorp Production SA are trading at €34.40. This share price information is delayed by 15 minutes.
How has the Biocorp Production SA share price performed this year?
Shares in Biocorp Production SA last closed at €34.40 and the price had moved by +63.81% over the past 365 days. In terms of relative price strength the Biocorp Production SA share price has outperformed the FTSE Global All Cap Index by +50.1% over the past year.
What are the analyst and broker recommendations for Biocorp Production SA?
The overall consensus recommendation for Biocorp Production SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Biocorp Production SA dividend yield?
Biocorp Production SA does not currently pay a dividend.
Does Biocorp Production SA pay a dividend?
Biocorp Production SA does not currently pay a dividend.
When does Biocorp Production SA next pay dividends?
Biocorp Production SA does not currently pay a dividend.
How do I buy Biocorp Production SA shares?
To buy shares in Biocorp Production SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Biocorp Production SA?
As of the previous close price of €34.40, shares in Biocorp Production SA had a market capitalisation of €151.31m.
Where are Biocorp Production SA shares listed?
Here are the trading details for Biocorp Production SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALCOR
What kind of share is Biocorp Production SA?
Based on an overall assessment of its quality, value and momentum Biocorp Production SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Biocorp Production SA share price forecast for 2023?
The analyst consensus target price for shares in Biocorp Production SA is €35.30. That is 2.62% above the last closing price of €34.40.
Analysts covering Biocorp Production SA currently have a consensus Earnings Per Share (EPS) forecast of €0.13 for the next financial year.
What is the trend in the Biocorp Production SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biocorp Production SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +45.09%.
As of the last closing price of €34.40, shares in Biocorp Production SA were trading +43.61% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Biocorp Production SA PE Ratio?
The Biocorp Production SA PE ratio based on its reported earnings over the past 12 months is 113.23. The shares last closed at €34.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Biocorp Production SA?
Biocorp Production SA's management team is headed by:
- Jacques Gardette - CHM
- Eric Dessertenne - CEO
- Stephane Chabanais - FID
- Alexia Garin - OTH
- Thierry Guillemaut - OTH
- Arnaud Guillet - OTH
- Xavier Julia - OTH
- Alain Marcoz - OTH
- Jean-Yves Berthon - DRC
- Emilie Gardette - DRC
- Julien Gardette - DRC
- Stephane Legastelois - DRC